News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial


12/13/2010 6:47:11 AM

(Reuters) - A small trial of Cytokinetics Inc's experimental drug for patients suffering from amyotropic lateral sclerosis, commonly known as Lou Gehrig's disease, found that it improved muscle response in some patients. The patients in the Phase 2a trial were treated with either a single 500 mg dose of the drug, known as CK-2017357, or a 250 mg dose, as well as a placebo.

Read at Reuters
Read at Yahoo Finance
Read at ABC News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES